Quarterly Financial Data (Unaudited) (Schedule Of Quarterly Financial Data) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Quarterly Financial Data [Abstract]
Total revenues	$ 1,241,513	$ 884,335	$ 920,887	$ 963,539	$ 1,073,697	$ 745,727	$ 735,166	$ 714,128
Gross profit	484,935	326,863	288,669	274,834	263,629	303,268	296,308	329,862
(Loss) income from continuing operations	(3,333,325)	(191,496)	389,812	(88,763)	443,709	(803,706)	(90,894)	150,492	$ (3,223,788)	$ (300,116)	$ 62,007
Discontinued operations, net of tax	(4,531)	(27,423)	(46,216)	(45,108)	(562,302)	(246,782)	(159,632)	(226,210)	(123,278)	(1,194,926)	(783,326)
Net (loss) income attributable to Endo International plc	$ (3,337,856)	$ (218,919)	$ 343,578	$ (133,869)	$ (118,463)	$ (1,050,442)	$ (250,419)	$ (75,718)	$ (3,347,066)	$ (1,495,042)	$ (721,319)
Continuing operations, basic (in dollars per share)	$ (14.96)	$ (0.86)	$ 1.75	$ (0.40)	$ 1.98	$ (3.84)	$ (0.49)	$ 0.89	$ (14.48)	$ (1.52)	$ 0.42
Discontinued operations, basic (in dollars per share)	(0.02)	(0.12)	(0.21)	(0.20)	(2.51)	(1.18)	(0.86)	(1.34)	(0.55)	(6.07)	(5.33)
Basic (in dollars per share)	(14.98)	(0.98)	1.54	(0.60)	(0.53)	(5.02)	(1.35)	(0.45)	(15.03)	(7.59)	(4.91)
Continuing operations, diluted (in dollars per share)	(14.96)	(0.86)	1.75	(0.40)	1.97	(3.84)	(0.49)	0.85	(14.48)	(1.52)	0.40
Discontinued operations, diluted (in dollars per share)	(0.02)	(0.12)	(0.21)	(0.20)	(2.50)	(1.18)	(0.86)	(1.28)	(0.55)	(6.07)	(5.00)
Diluted (in dollars per share)	$ (14.98)	$ (0.98)	$ 1.54	$ (0.60)	$ (0.53)	$ (5.02)	$ (1.35)	$ (0.43)	$ (15.03)	$ (7.59)	$ (4.60)
Weighted average shares—Basic (shares)	222,870	222,767	222,667	222,302	224,147	209,274	185,328	169,653	222,651	197,100	146,896
Weighted average shares—Diluted (shares)	222,870	222,767	222,863	222,302	225,321	209,274	185,328	176,825	222,651	197,100	156,730
Acquisition-related and integration items	$ 7,400	$ 19,500	$ 48,200	$ 12,600	$ 54,100	$ (27,700)	$ 44,200	$ 34,600	$ 87,601	$ 105,250	$ 77,384
Change in fair value of contingent consideration	(1,000)	11,600	23,900	(10,700)	17,900	(80,300)	(2,500)	(800)	23,823	(65,640)	0
Asset impairment charges	3,518,100	93,500	40,000	129,600	139,900	923,600	70,200	7,000	3,781,165	1,140,709	22,542
Inventory step-up	13,900	14,200	29,100	68,500	117,700	42,900	48,900	39,900	108,768	232,461	65,582
Severance costs	37,100	9,800	22,200	38,500	55,200	22,700	5,800	41,800	57,900	60,200	14,400
Litigation-related and other contingencies, net		$ 18,300	$ 5,300	$ 5,200	17,200		6,900	13,000	23,950	37,082	42,084
Reduction to legal fees	$ (4,800)
Loss on extinguishment of debt					$ 25,600	40,900		1,000
Costs associated with unused financing commitments						$ 64,300	2,300	11,800	0	78,352	0
Other-than-temporary impairment of equity investment							$ 18,900		$ 0	18,869	$ 0
Acceleration of Auxilium employee equity awards at closing								$ 37,600		$ 37,600